Search results for

The investigation into Chinese political elites would "wipe out everything we've tried to build there," Matthew Winkler, Bloomberg's editor-in-chief at the time, said on audiotape obtained by NPR.

In the digital era, accusations of surreptitious chart manipulation are common throughout the world — in South Korea, it's called sajaegi.

Nadkarni, an ecologist who knows a lot about the tree canopy, answers three questions about canapés, those delicious little hors d'oeuvres. Originally broadcast Oct. 26, 2019.

Senate takes up the COVID-19 relief package. New York Gov. Cuomo promises to comply with an investigation into allegations of workplace harassment. Myanmar marks its most violent day since the coup.

Juneteenth has been signed into law as a federal holiday. As U.S. prepares to pull troops out of Afghanistan, allies are left behind in danger. And, Iranians elect a new president.

The Senate may sign off on a $1 trillion infrastructure bill. The Pentagon moves to make vaccines mandatory for service members. As Taliban fighters gain ground, what is the global community doing?

The country's top infectious disease doctor says he is looking for "a level of control" over COVID-19 such that it is less disruptive to society — and again stressed the importance of vaccination.

The White House waited to disclose a second meeting between President Trump and Vladimir Putin at the G-20. Also, tensions have increased outside a holy site in Jerusalem following a shooting.

The Biden administration has delivered a plan to Russia offering a diplomatic way to resolve the crisis over Ukraine. NPR's Ari Shapiro talks with State Dept. spokesman Ned Price about the situation.

Merck documents show that in 2000, the maker of Vioxx tried to censor critics of the drug's safety. That was the year that drug giant Merck learned that Vioxx might cause heart attacks and other problems. The documents show a concerted effort by the company to identify doctors who were raising questions about the drug's safety and to put pressure on them to stop making critical comments. A spokesman for Merck denies the allegations.